Extravascular hemolytic attack after eculizumab therapy for paroxysmal nocturnal hemoglobinuria

Ann Hematol. 2012 Jul;91(7):1139-41. doi: 10.1007/s00277-011-1368-z. Epub 2011 Nov 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Blood Vessels / drug effects
  • Hematologic Agents / adverse effects
  • Hematologic Agents / therapeutic use
  • Hemoglobinuria, Paroxysmal / drug therapy*
  • Hemolysis / drug effects*
  • Humans
  • Male
  • Recurrence

Substances

  • Antibodies, Monoclonal, Humanized
  • Hematologic Agents
  • eculizumab